In addition to these effects in the brain, GPR37L1 has a reported role in maintaining blood pressure homeostasis (Min et al., 2010; Coleman et al., 2018; Zheng et al., 2018), and may represent a potential drug target for the treatment of hypertension (Smith, 2015). The gene discussed is GPR37L1; the disease is Hypertension.